Dr. Gil Sambrano, Vice President Portfolio & Review All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the … Continue reading Month of CIRM: Reviewing Review
Grants working group
CIRM Board invests $5 million in emergency funding for coronavirus
Coronavirus In response to the crisis caused by the COVID-19 virus in California and around the world the governing Board of the California Institute for Regenerative Medicine (CIRM) today held an emergency meeting to approve $5 million in rapid research funds targeting the virus. “These are clearly extraordinary times and they require an extraordinary response … Continue reading CIRM Board invests $5 million in emergency funding for coronavirus
CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients
Nearly half a million Americans with kidney disease are on dialysis, so it’s not surprising the CIRM Board had no hesitation, back in July 2016, in funding a program to make it easier and safer to get that life-saving therapy. That's why it’s gratifying to now hear that Humacyte, the company behind this new dialysis … Continue reading CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients
A Noble pursuit; finding the best science to help the most people
Mark Noble, Ph.D., is a pioneer in stem cell research and the Director of the University of Rochester Stem Cell and Regenerative Medicine Institute in New York. He is also a member of CIRM’s Grants Working Group (GWG), the panel of independent scientific experts we use to review research applications for funding and decide which … Continue reading A Noble pursuit; finding the best science to help the most people
A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
At CIRM we have our focus very clearly on the future, on accelerating stem cell therapies to patients with unmet medical needs. But every once in a while, it’s a good idea to look back at what you have already done. Knowing where you came from can help you get to where you are heading. … Continue reading A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
The Stem Cellar 